Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors

Gynecologic Oncology

Volumn 77, Issue 3, 2000, Pages 369-376

  Huang, Lee Wen ^a,d   Garrett, Audrey P ^a   Bell, Debra A ^c   Welch, William R ^b   Berkowitz, Ross S ^a   Mok, Samuel C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ISH; MMP 9; mRNA; Ovarian tumor; TIMP 1

Indexed keywords

GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER GROWTH; CELL INVASION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPITHELIUM TUMOR; HUMAN; HUMAN TISSUE; METASTASIS; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034043943     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5806     Document Type: Article

References (28)

1. Landis S H, Murray T, Bolden S, Wingo P A. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
2. Liotta L A, Stetler-Stevenson W G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51:1991;5054s-5059s.
3. Chambers A F, Matrisian L M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 89:1997;1260-1270.
4. Matrisian L M. Metalloproteinases and their inhibitors in matrix remodeling. Trend Gene. 6:1990;121-125.
5. Cawston T E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther. 70:1996;163-182.
6. Himelstein, B, P, Canete-Soler, R, Berhnhard, E, J, Dilks, D, W, Muschel, R, J: Metalloproteinases in tumor progression: the contribution of MMP-9. Invas Metast14:246-258, 1994-1995.
7. Naylor M S, Stamp G W, Davies B D, Balkwill F R. Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer. 58:1994;50-56.
8. Sugiura Y, Shimada H, Seeger R C, Laug W E, DeClerck Y A. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58:1998;2209-2216.
9. Zeng Z S, Cohen A M, Guillem J G. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinase 2 and 9 (MMP-2 ad MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 20:1999;749-755.
10. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb W H, Weis B, Ben-Baruch G, Reich R. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol. 72:1999;380-386.
11. Murray G I, Duncan M E, Arbuckle E, Melvin W T, Fothergill J E. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 43:1998;791-797.
12. Remacle A G, Noel A, Duggan C, McDermott E, O'Higgins N, Foidart J M, Duffy M J. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer. 77:1998;926-931.
13. Lampert K, Machein U, Machein M R, Conca W, Peter H H, Volk B. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Am J Pathol. 153:1998;429-437.
14. Denhardt D T, Feng B, Edwards D R, Cocuzzi E T, Malyankor U M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther. 59:1993;329-341.
15. Stetler-Stevenson W G, Liotta L A, Kleiner D E Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441.
16. Kruger A, Sanchez-Sweatman O H, Martin D C, Fata J E, Ho A T, Orr F W, Ruther U, Khokha R. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of fibrosarcoma cell line. Oncogene. 16:1998;2419-2423.
17. Nuova G J, MacConnell P B, Simsir A, Valea F, French D L. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55:1995;267-275.
18. Serov, S, F, Scully, R, E, Sobin, L, H: Histological Typing of Ovarian Cancer Tumors. Number 91, WHO, Geneva, Switzerland, pp. 37-41, 1973.
19. Sinicrope F A, Ruan S B, Cleary K R, Stephens L C, Lee J J, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55:1995;237-241.
20. Greene G F, Kitadai Y, Pettaway C A, von Eschenbach A C, Bucana C D, Fidler I J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol. 150:1997;1571-1582.
21. Docherty A J, Lyons A, Smith B J, Wright E M, Stephens P E, Harris T J, Murphy G, Reynolds J J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 318:1985;66-69.
22. Bucana C D, Radinsky R, Dong Z, Sanchez R, Brigati D J, Fidler I J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdrl in mouse colon carcinoma cells. J Histochem Cytochem. 41:1993;499-506.
23. Moser T L, Young T N, Rodriguez G C, Pizzo S V, Bast R C Jr, Stack M S. Secretion of extracellular matrix-degrading proteinase is increased in epithelial ovarian carcinoma. Int J Cancer. 56:1994;552-559.
24. Pyke C, Ralfkiær E, Tryggvason K, Danø K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 142:1993;359-365.
25. Nielsen B S, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Danø K. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer. 65:1996;57-62.
26. Kikkawa F, Tamakoshi K, Nawa A, Shibata K, Yamagata S, Yamagata T, Suganuma N. Positive correlation between inhibitors of matrix metalloproteinase l and matrix metalloproteinases in malignant ovarian tumor tissues. Cancer Lett. 120:1997;109-115.
27. Bertaux B, Hornebeck W, Eisen A Z, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol. 97:1991;679-685.
28. Chesler L, Golde D W, Bersch N, Johnson M D. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood. 86:1995;4506-4515.